Development of Hydrogel Microparticle based RT-qPCR for Advanced Detection of BCR-ABL1 Transcripts
- Authors
- Kim, Jung Min; Kim, Won Jin; Kim, Mi Yeon; Kim, Kwang Pyo; Sim, Sang Jun; Kim, Sang Kyung
- Issue Date
- 6월-2019
- Publisher
- KOREAN BIOCHIP SOCIETY-KBCS
- Keywords
- N Real-time PCR; RT-qPCR; Hydrogel microparticle; TaqMan probe; Chronic myeloid leukemia; BCR-ABL
- Citation
- BIOCHIP JOURNAL, v.13, no.2, pp.182 - 190
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- BIOCHIP JOURNAL
- Volume
- 13
- Number
- 2
- Start Page
- 182
- End Page
- 190
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/65271
- DOI
- 10.1007/s13206-018-3209-9
- ISSN
- 1976-0280
- Abstract
- Reverse transcription - quantitative polymerase chain reaction (RT-qPCR) is conventionally used method to analyze oncogenes, infected DNAs, and mutated tumor associated genes. However it is hard to detect rare genetic targets since the disturbance of undesired amplification often overrides the reaction of very few targets in a myriad of interfering genes. To solve the limitation, we developed primerimmobilized network (PIN) probe RT-qPCR which can detect target RNA with high selectivity and sensitivity. To conduct PIN probe RT-qPCR with high efficiency, design of probe, concentration of immobilized probe and qPCR condition were optimized. The LOD of PIN probe RT-qPCR was 40pg per particle with 89.2% efficiency. When extremely low concentration of RNA was used, result of PIN probe RTqPCR was showed on/off signal. Also, target was confirmed only in the on particle. The interference effects by non-target PCR products were minimized by target-capturing and washing process in the RT. Using PIN probe RT-qPCR, we successfully detected target RNA in a sample which has a ratio of 1:100,000 (positive RNA : negative RNA).
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Engineering > Department of Chemical and Biological Engineering > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.